“…administration of apoptotic spleen cells, simultaneously with BM grafts, favored engraftment via a TGF-b-dependent mechanism. 35 As TGF-b can be implicated in the generation of Treg subpopulations, 9,[13][14][15] and as fluorescent apoptotic bodies within splenic phagocytes could be found (Figure 1a), we first analyzed the spleen for the presence of CD4 þ CD25 þ T cells at weeks 7-9 post-BMT. Analysis of splenic T-cell populations in mice given apoptotic cells revealed a CD4 þ CD25 þ T-cell increase in engrafted versus nonengrafted recipients (8.870.6 versus 3.970.4%, mean7S.E.M., 10 mice per group, Po0.01, Figure 2a).…”